Dedeepya SD, Goel V, Desai NN. Comment on "Baseline hemoglobin and neutrophil-to-lymphocyte ratio as prognostic biomarkers in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan in second line and beyond: a real-world analysis". Breast Cancer Res Treat 2025;215:29.
PMID: 41348236